(Q34390814)

English

Ebrotidine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

Ebrotidine (English)

1 reference

Europe PubMed Central

1 August 2017

0 references

author name string

Patel SS

1

1 reference

Europe PubMed Central

1 August 2017

Wilde MI

2

1 reference

Europe PubMed Central

1 August 2017

publication date

1 June 1996

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

51

1 reference

Europe PubMed Central

1 August 2017

6

1 reference

Europe PubMed Central

1 August 2017

974-80; discussion 981

1 reference

Europe PubMed Central

1 August 2017

https://scigraph.springernature.com/pub.10.2165/00003495-199651060-00006

0 references

Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of ebrotidine compared with ranitidine in patients with duodenal ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of gastric mucosal calcium channel activity by an antiulcer agent, ebrotidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric acid inhibitory profile of ebrotidine, a novel H2-receptor antagonist in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ebrotidine on the density of antral G-cells in the gastric mucosa in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastroprotective and antisecretory effects of ebrotidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement in the protective qualities of gastric mucus by ebrotidine during duodenal ulcer healing

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of ebrotidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of the metabolism of ebrotidine in human urine by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of ebrotidine on aspirin-induced gastric mucosal damage and blood flow in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of Helicobacter pylori urease activity by ebrotidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. 1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolites of ebrotidine, a new H2-receptor antagonist, in human urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of ebrotidine protection against gastric mucosal injury induced by ethanol

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of gastric mucus phospholipid secretion by an antiulcer agent, ebrotidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric mucosal laminin receptor expression with ulcer healing by ebrotidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ebrotidine effect on the proteolytic and lipolytic activities of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathogenesis of peptic ulcer and implications for therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind crossover study of ranitidine and ebrotidine in gastro-esophageal reflux disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastroprotective and ulcer-healing activities of a new H2-receptor antagonist: ebrotidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8736619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199651060-00006

1 reference

Europe PubMed Central

1 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34390814&oldid=1972785780"